137 related articles for article (PubMed ID: 238716)
1. Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
Roy P; Day L; Sowton E
Br Med J; 1975 Jul; 3(5977):195-7. PubMed ID: 238716
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
Jackson G; Atkinson L; Oram S
Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
[TBL] [Abstract][Full Text] [Related]
3. Practolol in treatment of angina pectoris. A double-blind trial.
George CF; Nagle RE; Pentecost BL
Br Med J; 1970 May; 2(5706):402-4. PubMed ID: 4392984
[TBL] [Abstract][Full Text] [Related]
4. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
5. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
Libretti A; Gregorini L; Valentini R
Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
[No Abstract] [Full Text] [Related]
6. Effect of practolol on exercise tolerance in patients with angina pectoris.
Sowton E; Smithen C; Leaver D; Barr I
Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
[No Abstract] [Full Text] [Related]
7. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
Sandler G; Clayton GA
Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
[TBL] [Abstract][Full Text] [Related]
8. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
Ekelund LG; Olsson AG; Orö L; Rössner S
Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
[TBL] [Abstract][Full Text] [Related]
9. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
[TBL] [Abstract][Full Text] [Related]
10. Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study.
Stroobandt R; Kesteloot H
Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):299-309. PubMed ID: 6143538
[TBL] [Abstract][Full Text] [Related]
11. Beta adrenergic blocking agents for exertional angina pectoris.
Thadani U
Herz; 1982 Jun; 7(3):179-87. PubMed ID: 6124493
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
Keyriläinen O; Uusitalo A
Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
Furberg B; Dahlqvist A; Raak A; Wrege U
Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
[TBL] [Abstract][Full Text] [Related]
14. Practolol in angina pectoris: a double-blind ergometric study.
Bäckman H; Martikainen T
Ann Clin Res; 1974 Dec; 6(6):347-55. PubMed ID: 4217578
[No Abstract] [Full Text] [Related]
15. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
Arstila M; Iisalo E; Kallio V
Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
[No Abstract] [Full Text] [Related]
16. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
Uusitalo AJ; Keyriläinen O
Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.
Dwyer EM; Pepe AJ; Pinkernell BH
Am Heart J; 1982 May; 103(5):830-3. PubMed ID: 6803556
[TBL] [Abstract][Full Text] [Related]
18. Clinical investigations into the effects of practolol in angina pectoris.
Chlebus H; Jarecki M; Waclawek J; Kadzielawa R
Cor Vasa; 1977; 19(1):1-11. PubMed ID: 326482
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
[TBL] [Abstract][Full Text] [Related]
20. Atenolol once daily in angina.
Mäkynen P; Karhumäki L; Seppänen S
Ann Clin Res; 1979 Apr; 11(2):53-7. PubMed ID: 110212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
